We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
News

Cannabis to be Assessed as an Alternative to Fentanyl in Pivotal Clinical Trial

The trial is designed to assess the time-to-relief in patients suffering from severe pain.

Read More

DEA Green-lights Novel Cannabinoid Research

The research will build on previous findings that could enhance the performance of other cancer therapeutics such as checkpoint inhibitors, which activate the immune system to destroy cancer cells.

Read More

Enhancing the Bioavailability of Cannabinoids

Researchers are striving to develop a full-profile, non-psychoactive cannabis extract product to help meet unmet medical needs.

Read More

Supra THC Obtains ISO 17025 Accreditation

Securing testing results from an ISO 17025 accredited laboratory is the best way for cannabis producers to ensure that they are producing high-quality, safe products.

Read More

Cannabis Does Not Increase Suicidal Behavior In Psychiatric Patients

Recent findings contrast with pre-existing data that shows the drug is linked to an increased chance of suicidal behaviour in the general population.

Read More

Quadron Expands Product Range to Capitalize on Extracts

While cannabis flower characterized the market in the early years, cannabis extracts have become increasingly popular and eclipsed cannabis flower sales this year.

Read More

Aurora Acquires Anandia Labs for $115M

Anandia plans to accelerate their current breeding efforts to create the next-generation of cannabis plants and, expand their testing capabilities.

Read More

A Big Step Forward for Medical Marijuana

Medical marijuana has picked up considerable momentum after a U.S. FDA advisory panel unanimously recommended approval of GW Pharmaceuticals' epilepsy medication, Epidolex.

Read More

Multiple Sclerosis Study Could Push Cannabis Compounds Closer to FDA Approval

MMJ is seeking to scientifically assess and prove the effectiveness of their THC/CBD compounds treating and preventing symptoms associated with multiple sclerosis.

Read More

 
Advertisement